A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
European Study on Intravenous Immunoglobulin in Multiple Sclerosis
2004
Archives of Neurology
Magnetization transfer magnetic resonance imaging (MT MRI) can provide in vivo markers reflecting the severity of multiple sclerosis-related brain damage occurring within and outside T2-visible lesions. Objective: To investigate the effect of intravenous immunoglobulin (IVIG) treatment on the accumulation of brain damage in patients with secondary progressive multiple sclerosis (SPMS), measured using MT MRI. Design, Patients, and Intervention: Seventy patients with SPMS participating in the
doi:10.1001/archneur.61.9.1409
pmid:15364687
fatcat:psvleu2zrvgypcf4qios4wbmx4